Contract manufacturer Siegfried amps up in China with new plant

Switzerland-based contract manufacturer Siegfried has decided to join the construction line in China with a Nantong plant expected to start turning out drug products by mid-2014. Other parts of Siegfried's manufacturing operations are getting a dose of expansion, too. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.